The site is temporarily down due to maintenance. Sorry for the inconvenience.

The site is temporarily down due to maintenance. Sorry for the inconvenience.

СА 72-4 - carcinoma antigen (blood)

Known as: CA 72-4 – carcinoma antigen
SKU: 9040

115.00

Study material: Venous blood
Response time (working day): 14
The test is done on an empty stomach: no
Home call service: Yes
Country: EU

General Information

CA 72-4 (carcinoma antigen) is a tumor marker used in the monitoring of gastrointestinal and gynecological tumors. It is particularly important in the evaluation of gastric cancer and carcinomas of the cervix/uterine body.

SA 72-4

 

 

It is a first-line marker for monitoring the treatment and progression of gastric tumors (along with CEA and CA 19-9).

A secondary marker in the monitoring process of mucinous ovarian tumors.

 

When should we take the test?

  • When stomach cancer is suspected → Especially in the case of adenocarcinoma
  • Cervical/corpus carcinoma
  • Colorectal cancer → Additional, non-specific marker
  • For treatment monitoring → After chemotherapy and surgery
  • When a relapse is detected → Dynamic observation

Possible interpretation of the results

  • High level → May indicate stomach, ovarian, uterine, or colorectal cancer
  • Low/normal level → Does not rule out cancer because CA 72-4 is not a screening test
  • Dynamics → More reliable than a single indicator; assesses treatment effectiveness and relapse

Reference values

Preparation of the patient:it is not necessary

Study sample:Venous blood

Treatment with high doses of biotin (>5 mg/day) affects marker values. Therefore, it is advisable to collect the sample at least 8 hours after the last dose of biotin.

 

Order tests online

Learn more


Testing process

Purchase a test Submission of material

Purchase a test

Submission of material

Results Online Consult a doctor

Results Online

Consult a doctor

Laboratories
Select a location
Synevo place picture
4.9
Based on 273 reviews
This medical information is not intended to be a universal treatment guide for all patients. The treatment process, including the type, volume, and frequency of diagnostic tests and therapeutic procedures, is determined by the physician individually — based on an assessment of the patient's condition and relevant medical indications. The decision is made in consultation with the patient. Before purchasing a test, please read the instructions for its preparation.
Call Now Button